Fortis Healthcare shares gain as analysts see up to 25% upside post solid Q3

Brokerages UBS and Citi have ‘buy’ recommendations on the Fortis Healthcare stock while JPMorgan has an ‘overweight’ rating. 

Leave a Reply

Your email address will not be published. Required fields are marked *